IPSEY 株価推移チャート
IPSEY 財務
Ipsen S.A.
$48.86
-3.63%
$-1.84
終値： May 08, 16:00:00 GMT-4
$48.86
0%
$0
アフターマーケット：May 08, 20:00:00 GMT-4
戻る
Ipsen S.A. (IPSEY) 財務
主要データ
前終値
$50.7
始値
$48.86
当日レンジ
$48.86 - $50.88
52週レンジ
$28.03 - $51.1
取引高
2
平均取引高
806
配当利回り
--
1株当たり利益(TTM)
1.56
時価総額
$16.1B
Ipsen S.A.とは何ですか？
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. The company employs 5,535 full-time employees The company went IPO on 2005-12-06. The firm operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and Increlex. Its primary care portfolio includes Smecta, Forlax, Fortrans, Eziclen, and Tanakan. In oncology Ipsen focuses on a number of disease areas, which include neuroendocrine tumors, renal cell carcinoma, hepatocellular carcinoma and pancreatic cancer. In addition, the Company has specialism in neurotoxin research and operates three research and development centers located in France, the United Kingdom and the United States.
